Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Request for Nominations--Comment from the National Home Infusion Association

Comment from the National Home Infusion Association

• See Attached

• Public Submission
• Posted:
  03/13/2014
• ID:
  FDA-2013-N-1523-0011